Patient P-03029
Therapy response
Declining
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
29%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S13
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+14
- Treatment adherence+9
- Nutritional resilience-8
- Toxicity-8
- Inflammatory activity+5
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log6.3/10
stable · -0.2 vs previous 14 d
Stress level
Daily log3.1/10
worsening · +0.5 vs previous 14 d
Pessimism score
Daily log2.6/10
worsening · +0.2 vs previous 14 d
Sleep quality
Wearable34.8/100
worsening · -8.6 vs previous 14 d
Libido
Daily log6/10
worsening · -0.3 vs previous 14 d
HRV
Wearable60.4 ms
worsening · -3.2 vs previous 14 d
Toxicity
Blood7.8/100
improving · -3.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 81 from the failing basin, 11 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.5 next day on high-intake days · n 17
- More histamineGI -2.3 next day on high-intake days · n 17
Would not help
- Keep lactose lowGI +4.5 next day on high-intake days · n 20
- Keep alcohol lowGI +2.9 next day on high-intake days · n 20
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Lactose+4.5detractor · 95%
- Protein-3.5supporter · 95%
- Alcohol+2.9detractor · 82%
- Histamine load-2.3supporter · 64%
- Dietary fat load+1no signal · 27%
- Caffeine-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑45
- WearableResting HR 76 bpm
- WearableShort sleep window
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
- Mucosal barrier integrity ↓10
- WearableSleep 5.8 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 67/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 56 ms
- Sleep
- 6.0 h
- Steps
- 5,710
- Resting HR
- 74 bpm
Daily log: GI score 28, nutritional resilience 62, adherence 98.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03140 | 44% | S20 | AD-05 | improved | 79 |
| P-03187 | 37% | S12 | AD-05 | no change | 80 |
| P-03105 | 30% | S12 | AD-05 | no change | 60 |
| P-03482 | 29% | S05 | AD-05 | no change | 67 |
| P-03208 | 31% | S02 | BR-03 | improved | 57 |
| P-03288 | 45% | S15 | CR-01 | improved | 88 |
| P-03001 | 44% | S04 | CR-01 | improved | 87 |
| P-03431 | 42% | S05 | DT-01 | improved | 88 |
| P-03353 | 40% | S06 | DT-01 | no change | 83 |
| P-03449 | 37% | S14 | DT-01 | improved | 79 |
| P-03473 | 31% | S07 | DT-01 | improved | 70 |
| P-03193 | 29% | S13 | DT-01 | improved | 53 |